Assays

Sannova is continuously developing and validating new analytical methods that meet the high internal standards we set for ourselves regarding accuracy and precision. Our clients include large, midsized, and small companies working to produce products ranging from generic drugs, 505 (b) (2) settings, and innovative new chemical entities (NCE) in a wide array of therapeutic areas; small molecules, peptides, proteins and inorganic species.

Please see our list of validated methods for non-proprietary drugs, or contact us for updates to our method list or to explore opportunities for the development and validation of methods for new chemical entities.

S Compound (Analyte) Matrix Senstivity Units Method Status
A Abacavir Plasma 20.000 ng/mL LC/MS/MS Validated
A Axitinib Plasma 0.404 ng/mL LC/MS/MS Validated
A Abiraterone Plasma 0.640 ng/mL LC/MS/MS Validated
A Acamprosate   Plasma 1.920 ng/mL LC/MS/MS Validated
A Acarbose (Glucose) Serum 44.000 mg/dL LC/MS/MS Validated
A Acetaminophen
Caffeine
Plasma 40.000
20.000
ng/mL
ng/mL
LC/MS/MS Validated
A Acetyl Salicylic Acid
Salicylic Acid
Plasma 20.396
101.109
ng/mL
ng/mL
LC/MS/MS Validated
A Adefovir Plasma 1.120 ng/mL LC/MS/MS Validated
A Alfuzosin Plasma 0.300 ng/mL LC/MS/MS Validated
A Allopurinol Plasma 0.100 µg/mL LC/MS/MS Validated
A All trans-Acitretin
13 Cis-Acitretin
Plasma 2.552
0.507
ng/mL LC/MS/MS Validated
A Amantadine Plasma 1.847 ng/mL LC/MS/MS Validated
A Amlodipine Plasma 0.100 ng/mL LC/MS/MS Validated
A Aripiprazole Plasma 0.180 ng/mL LC/MS/MS Validated
A Argatroban Plasma 20.000 ng/mL LC/MS/MS Validated
A Argatroban Plasma 0.075 µg/mL LC/MS/MS Validated
A Asenapine Plasma 0.188 ng/mL LC/MS/MS Validated
A Asenapine
N-Desmethyl Asenapine
Plasma 0.100
0.100
ng/mL LC/MS/MS Validated
A Atorvostatin
Ortho-Hydroxy Atorvastatin          
Para-Hydroxy Atorvastatin
Plasma 0.512
0.256
0.102
ng/mL
ng/mL
ng/mL
LC/MS/MS Validated
A Azithromycin Plasma 4.000 ng/mL LC/MS/MS Validated
A Azathioprine
6-Mercaptopurine
Plasma 1.275
3.240
ng/mL LC/MS/MS Validated
A Azo-Procarbazine Plasma 0.250 ng/mL LC/MS/MS Validated
A Azo-Procarbazine Plasma 5.052 ng/mL LC/MS/MS Validated
A Benazapril
Benazaprilate
Plasma 5.000
5.000
ng/mL
ng/mL
LC/MS/MS Validated
A Bexarotene      Plasma 2.000 ng/mL LC/MS/MS Validated
A Bortezomib Plasma 0.802 ng/mL LC/MS/MS Validated
A Budesonide Plasma 31.000 pg/mL LC/MS/MS Validated
A Bupropion and
Hydroxy Bupropion
Plasma 1.000
3.000
ng/mL LC/MS/MS Validated
A Bupropion
Hydroxy Bupropion
Erythro dihydro Bupropion and
Threo dihydro Bupropion
Plasma 1.075
For all analytes
ng/mL LC/MS/MS Validated
A Buprenorphine
Norbuprenorphine
Plasma 0.152
0.203
ng/mL LC/MS/MS Validated
A Chlorthalidone Plasma 1.024 ng/mL LC/MS/MS Validated
A Cinacalcet Plasma 0.515 ng/mL LC/MS/MS Validated
A Cabergoline    Plasma 2.000 pg/mL LC/MS/MS Validated
A Calcitriol Plasma 2.000 ng/mL LC/MS/MS Validated
A Candesartan Plasma 2.000 ng/mL LC/MS/MS Validated
A Candesartan
Nifedipine
Plasma 4.950
1.000
ng/mL
ng/mL
LC/MS/MS Validated
A Carbidopa Plasma 25.000 pg/mL LC/MS/MS Validated
A Carisoprodol Plasma 9.600 ng/mL LC/MS/MS Validated
A Cefixime Plasma 40.000 ng/mL LC/MS/MS Validated
A Celecoxib Plasma 10.000 ng/mL LC/MS/MS Validated
A Cetirizine
Pseudoephedrine
Plasma 1.938
4.013
ng/mL LC/MS/MS Validated
A Ciprofloxacin Plasma 0.020 µg/mL LC/MS/MS Validated
A Clobazam and its metabolite
N-Desmethyl Clobazam
Plasma 2.048
0.512
ng/mL
ng/mL
LC/MS/MS Validated
A Clonidine Plasma 10.283 pg/mL LC/MS/MS Validated
A Clopidogrel Plasma 0.040 ng/mL LC/MS/MS Validated
A Codiene Plasma 2.031 ng/mL LC/MS/MS Validated
A Cyclic GMP BEAGLE PLASMA 0.503 ng/mL LC/MS/MS Validated
A Cyclobenzaprine         Plasma 0.200 ng/mL LC/MS/MS Validated
A Cyclosporin Blood 4.116 ng/mL LC/MS/MS Validated
A Dabigatran Plasma 2.023 ng/mL LC/MS/MS Validated
A Dapsone Plasma 4.000 ng/mL LC/MS/MS Validated
A Dantrolene
OH-dantrolene
Porcine
Plasma
60.000
15.000
ng/mL LC/MS/MS Validated
A Desvenlafaxine Plasma 2.018 ng/mL LC/MS/MS Validated
A Desmopressin Plasma 2.063 pg/mL LC/MS/MS Validated
A Dexbrompheniramine
Pseudoephedrine
Plasma 0.249
2.097
ng/mL LC/MS/MS Validated
A Dexmethylphenidate Plasma 0.196 ng/ml LC/MS/MS Validated
A Dextroamphetamine Plasma 1.042 ng/mL LC/MS/MS Validated
A Dextroamphetamine
Levoamphetamine
Plasma 0.582
0.234
ng/mL LC/MS/MS Validated
A Dextromethorphan
Dextrorphan
Plasma 0.051
0.205
ng/mL LC/MS/MS Validated
A Dexlansoprazole Plasma 1.006 ng/mL LC/MS/MS Validated
A Diclofenac Plasma 9.643 ng/mL LC/MS/MS Validated
A Diethylpropion Plasma 1.152 ng/mL LC/MS/MS Validated
A Diethylpropion Plasma 0.250 ng/mL LC/MS/MS Validated
A Disulfiram(Secondary Metabolite)       Plasma 1.000 ng/mL LC/MS/MS Validated
A Docetaxel Plasma 5.400 ng/mL LC/MS/MS Validated
A Docetaxel Dog Plasma 5.700 ng/mL LC/MS/MS Validated
A Dofetilide Plasma 50.005 pg/mL LC/MS/MS Validated
A Donepezil Pig Plasma 0.200 ng/mL LC/MS/MS Validated
A Donepezil and
6-O-Desmethyl Donepezil
Plasma 0.206
40.625
ng/mL pg/mL LC/MS/MS Validated
A Donepezil &
Memantine
Plasma 0.202
0.201
ng/mL LC/MS/MS Validated
A Dronabinol
Hydroxy Dronabinol
Plasma 0.517
0.094
ng/mL LC/MS/MS Validated
A Dronabinol,
its metabolite Hydroxy Dronabinol and Cannabidiol
Plasma 96.750
93.750
93.750
pg/mL LC/MS/MS Validated
A Dronedarone
N-Desbutyl Dronedarone
Plasma 0.512
0.512
ng/mL LC/MS/MS Validated
A Dutasteride Plasma 0.096 ng/mL LC/MS/MS Validated
A Ethacrynic Acid Plasma 75.000 pg/mL LC/MS/MS Validated
A Enclomiphene Plasma 2.632 ng/mL LC/MS/MS Validated
A Erythromycin Plasma 23.883 ng/mL LC/MS/MS Validated
A Ethinyl estradiol &
Drosperinone
Plasma 2.063
0.516
pg/mL
ng/mL
LC/MS/MS Validated
A Ethinyl Estradiol
Levonorgestrel
Plasma 2.500
0.100
pg/mL
ng/mL
LC/MS/MS Validated
A Estradiol Plasma 1.942 pg/mL LC/MS/MS Validated
A Exemestane Plasma 0.300 ng/mL LC/MS/MS Validated
A Ezetimibe Plasma 0.170 ng/mL LC/MS/MS Validated
A Fentanyl Plasma 2.500 pg/mL LC/MS/MS Validated
A Fexofenadine
Pseudoephedrine
Plasma 2.160
1.115
ng/mL LC/MS/MS Validated
A Fexofenadine Plasma 2.600 ng/mL LC/MS/MS Validated
A Fenofibric acid Plasma 19.000 ng/mL LC/MS/MS Validated
A Fosinoprilat    Plasma 5.000 ng/mL LC/MS/MS Validated
A Free Erythromycin Plasma 2.048 ng/mL LC/MS/MS Validated
A Flucytosine Plasma 0.100 µg/mL LC/MS/MS Validated
A Fludrocortisone Plasma 50.000 pg/mL LC/MS/MS Validated
A Fluoxtine Plasma 0.480 ng/mL LC/MS/MS Validated
A Fluvastatin Plasma 1.033 ng/mL LC/MS/MS Validated
A Fulvestrant Plasma 0.781 ng/mL LC/MS/MS Validated
A Gabapentin     Plasma 40.00 ng/mL LC/MS/MS Validated
A Gabapentin     Plasma 0.040 µg/mL LC/MS/MS Validated
A Gemfibrozil Plasma 0.200 µg/mL LC/MS/MS Validated
A Glipizide Plasma 3.000 ng/mL LC/MS/MS Validated
A Glyburide Plasma 2.000 ng/mL LC/MS/MS Validated
A Hydrochlorothiazide  Plasma 2.000 ng/mL LC/MS/MS Validated
A Hydrocodone (less than 60mg dosage) Plasma 0.400 ng/mL LC/MS/MS Validated
A Hydrocodone (more than 60mg dosage) Plasma 1.000 ng/mL LC/MS/MS Validated
A Hydrocodone and
Acetaminophen
Plasma 0.203
49.282
ng/mL
ng/mL
LC/MS/MS Validated
A Hydrocodone and
Chlorpheniramine
Plasma 0.500
1.000
ng/mL LC/MS/MS Validated
A Hydrocodone and
Homatropine
Plasma 0.469
0.188
ng/mL LC/MS/MS Validated
A Hydrocodone
Acetaminophen
Promethazine
Plasma 0.200
50.000
0.210
ng/mL LC/MS/MS Validated
A Hydromorphone Plasma 0.100 ng/mL LC/MS/MS Validated
A Ibuprofen        Plasma 0.100 µg/mL LC/MS/MS Validated
A Irbesartan        Plasma 0.030 µg/mL LC/MS/MS Validated
A Irbesartan and
Hydrochlorothiazide             
Plasma 0.050
2.000
µg/mL
ng/mL
LC/MS/MS Validated
A Itraconazole
OH-Itraconazole
Plasma 2.000
2.600
ng/mL LC/MS/MS Validated
A Imiquimod Plasma 4.908 ng/mL LC/MS/MS Validated
A Isotretinoin Plasma 5.000 ng/mL LC/MS/MS Validated
A Isradipine        Plasma 0.100 ng/mL LC/MS/MS Validated
A Imipramine Plasma 0.500 ng/mL LC/MS/MS Validated
A Imipramine
Desipramine
Plasma 0.500
0.200
ng/mL LC/MS/MS Validated
A Lacosamide    Plasma 0.021 µg/mL LC/MS/MS Validated
A Lamotrigine Plasma 10.000 ng/mL LC/MS/MS Validated
A Lansoprazole Plasma 8.000 ng/mL LC/MS/MS Validated
A Leuprolide Serum 0.098 ng/mL LC/MS/MS Validated
A Levocetirizine Plasma 1.024 ng/mL LC/MS/MS Validated
A Levothyroxine Plasma 15.408 ng/mL LC/MS/MS Validated
A Lidocaine Plasma 0.200 ng/mL LC/MS/MS Validated
A Lidocaine
Prilocaine
Plasma 0.194
0.095
ng/mL LC/MS/MS Validated
A Linagliptin Plasma 0.052 ng/mL LC/MS/MS Validated
A Lisdexamfetamine
Dextroamphetamine
Plasma 1.000
1.000
ng/mL LC/MS/MS Validated
A Lisinopril Plasma 1.030 ng/mL LC/MS/MS Validated
A Lisinopril Plasma 2.048 ng/mL LC/MS/MS Validated
A Lisinopril
HCTZ
Plasma 1.030
1.960
ng/mL LC/MS/MS Validated
A Lorazepam Plasma 0.400 ng/mL LC/MS/MS Validated
A Lurasidone Plasma 1.029 ng/mL LC/MS/MS Validated
A Metaxalone     Plasma 40.000 ng/mL LC/MS/MS Validated
A Metformin      Plasma 20.000 ng/mL LC/MS/MS Validated
A Metoprolol      Plasma 2.500 ng/mL LC/MS/MS Validated
A Methotrexate Plasma 1.875 ng/mL LC/MS/MS Validated
A Methoxsalen Plasma 1.980 ng/mL LC/MS/MS Validated
A Methylnaltrexone Plasma 0.492 ng/mL LC/MS/MS Validated
A Methylphenidate Plasma 0.150 ng/mL LC/MS/MS Validated
A Methylphenidate Plasma 0.200 ng/mL LC/MS/MS Validated
A Memantine Plasma 0.214 ng/mL LC/MS/MS Validated
A Mesalamine Plasma 0.500 ng/mL LC/MS/MS Validated
A Minocycline Plasma 9.936 ng/mL LC/MS/MS Validated
A Mirabegron Plasma 0.305 ng/mL LC/MS/MS Validated
A Monomethyl Fumarate Plasma 31.385 ng/mL LC/MS/MS Validated
A Morphine
Morphine-6β-D-Glucuronide
Plasma 0.300
1.000
ng/mL LC/MS/MS Validated
A Morphine
Morphine-6β-D-Glucuronide
Plasma 0.773
25.625
ng/mL LC/MS/MS Validated
A Medroxyprogesterone Plasma 51.581 pg/mL LC/MS/MS Validated
A Nadolol Plasma 1.000 ng/mL LC/MS/MS Validated
A Naproxen        Plasma 0.600 µg/mL LC/MS/MS Validated
A Naloxone Plasma 11.250 pg/mL LC/MS/MS Validated
A Naloxone (Total) Plasma 0.063 ng/mL LC/MS/MS Validated
A Naltrexone
6β-Naltrexol
Plasma 0.033
0.154
ng/mL LC/MS/MS Validated
A Nebivolol Plasma 0.048 ng/mL LC/MS/MS Validated
A Nevirapine Plasma 10.200 ng/mL LC/MS/MS Validated
A Niacin and
Nicotinuric Acid
Plasma 5.000
2.500
ng/mL
ng/mL
LC/MS/MS Validated
A Nifedipine Plasma 1.005 ng/mL LC/MS/MS Validated
A Nilutamide Plasma 0.103 µg/mL LC/MS/MS Validated
A Nitrofurantoin Plasma 8.000 ng/mL LC/MS/MS Validated
A Olsalazine Plasma 10.000 ng/mL LC/MS/MS Validated
A Olanzapine Plasma 0.150 ng/mL LC/MS/MS Validated
A Omeprazole Plasma 4.063 ng/mL LC/MS/MS Validated
A Orphenadrine  Plasma 1.000 ng/mL LC/MS/MS Validated
A Oxazepam Plasma 2.600 ng/mL LC/MS/MS Validated
A Oxycodone Plasma 0.400 ng/mL LC/MS/MS Validated
A Oxycodone and
Acetaminophen
Plasma 0.400
46.000
ng/mL
ng/mL
LC/MS/MS Validated
A Oxymorphone
6β-Hydroxy Oxymorphone
Plasma 0.019
0.019
ng/mL
ng/mL
LC/MS/MS Validated
A Paliperidone Plasma 0.096 ng/mL LC/MS/MS Validated
A Paroxetine Plasma 0.200 ng/mL LC/MS/MS Validated
A PEG Uricase Rat Serum 2.904 µg/mL LC/MS/MS Validated
A Perphenazine Plasma 10.000 pg/mL LC/MS/MS Validated
A Pentermine Plasma 1.000 ng/mL LC/MS/MS Validated
A Pentermine &
Topiramate
Plasma 1.000
10.000
ng/mL
ng/mL
LC/MS/MS Validated
A PEG Uricase Monkey Serum 2.904 µg/mL LC/MS/MS Validated
A Phenelzine Plasma 0.800 ng/mL LC/MS/MS Validated
A Phenylbutyrate Plasma 0.200 µg/mL LC/MS/MS Validated
A Phenylbutyrate Plasma 0.518 µg/mL LC/MS/MS Validated
A Phytonadione E Isomer
Phytonadione Z Isomer
Plasma 0.182
0.159
ng/mL
ng/mL
LC/MS/MS Validated
A Polydatin Plasma 2.064 ng/mL LC/MS/MS Validated
A Polydatin Urine 20.480 ng/mL LC/MS/MS Validated
A Pravastatin Plas
ma
0.512 ng/mL LC/MS/MS Validated
A Prednisone &
Prednisolone
Plasma 0.500
4.000
ng/mL
ng/mL
LC/MS/MS Validated
A Pregabalin Plasma 50.000 ng/mL LC/MS/MS Validated
A Protriptyline Plasma 0.100 ng/mL LC/MS/MS Validated
A Procarbazine Plasma 0.700 ng/mL LC/MS/MS Validated
A Propylene Glycol Plasma 0.944 µg/mL LC/MS/MS Validated
A Phytonadione E Isomer
Phytonadione Z Isomer
Plasma 0.182
0.159
ng/mL
ng/mL
LC/MS/MS Validated
A Pyrimethamine Plasma 2.000 ng/mL LC/MS/MS Validated
A Pyridostigmine Plasma 0.410 ng/mL LC/MS/MS Validated
A Quinapril
Quinaprilat
Hydrochlorothiazide
Plasma 2.000
10.000
2.000
ng/mL
ng/mL
ng/mL
LC/MS/MS Validated
A Rabeprazole Plasma 2.048 ng/mL LC/MS/MS Validated
A Raloxifene and its Metabolites
4-glucuronide
6-glucuronide
Plasma 30.000
1.000
0.400
pg/mL
ng/mL
ng/mL
LC/MS/MS Validated
A Rasagiline Plasma 0.100 ng/mL LC/MS/MS Validated
A Rifaximin Plasma 0.046 ng/mL LC/MS/MS Validated
D Riluzole Plasma 0.499 ng/mL LC/MS/MS Validated
A Risedronate Plasma 0.400 ng/mL LC/MS/MS Validated
A Rizatriptan Plasma 0.469 ng/mL LC/MS/MS Validated
A Rivaroxaban Plasma 1.030 ng/mL LC/MS/MS Validated
A Rivastigmine Plasma 0.097 ng/mL LC/MS/MS Validated
A Rivastigmine
Memantine
Plasma 0.199
0.201
ng/mL
ng/mL
LC/MS/MS Validated
A Rosuvastatin Plasma 0.996 ng/mL LC/MS/MS Validated
A Rotigotine Plasma 5.000 pg/mL LC/MS/MS Validated
A Simvastatin
Simvastatin Acid
Plasma 0.202
0.054
ng/mL
ng/mL
LC/MS/MS Validated
A Simvastatin
Simvastatin Acid
Plasma 0.196
0.107
ng/mL
ng/mL
LC/MS/MS Validated
A Sulfasalazine and its metabolite Sulfapyridine Plasma 0.400 µg/mL LC/MS/MS Validated
A Tacrolimus Blood 0.970 ng/mL LC/MS/MS Validated
A Tapentadol     Plasma 1.024 ng/mL LC/MS/MS Validated
A Temazepam Plasma 3.072 ng/mL LC/MS/MS Validated
A Teriflunomide Plasma 9.375 ng/mL LC/MS/MS Validated
A Testosterone Serum 0.075 ng/mL LC/MS/MS Validated
A Testosterone
Dihydrotestosterone
Serum 48.384
49.920
pg/mL
pg/mL
LC/MS/MS Validated
A Ticagrelor
Deshydroxy Ethoxy Ticagrelor
Plasma 9.849
4.845
ng/mL ng/mL LC/MS/MS Validated
A Tobramycin Beagle Plasma 93.945 ng/mL LC/MS/MS Validated
A Topiramate Plasma 5.000 ng/mL LC/MS/MS Validated
A Torsemide      Plasma 0.010 µg/mL LC/MS/MS Validated
A Total Bile Acid Salts
(In-vitro Equilibrium binding)
In-vitro
Simulated
intestinal fluid
0.0500 mM LC/MS/MS Validated
A Total Bile Acid Salts (Kinetics) 0.1M Sodium
chloride solution
0.0500 mM LC/MS/MS Validated
A Total Erythromycin Plasma 23.809 ng/mL LC/MS/MS Validated
A Total Ezetimibe Plasma 3.000 ng/mL LC/MS/MS Validated
A Total Liothyronine Plasma 0.190 ng/mL LC/MS/MS Validated
A Total Naloxone Plasma 0.215 ng/mL LC/MS/MS Validated
A Tramadol Plasma 0.881 ng/mL LC/MS/MS Validated
A Treprostinil Plasma 19.561 pg/mL LC/MS/MS Validated
A Triamcinilone Acetonide                       Plasma 36.000 pg/mL LC/MS/MS Validated
A Trospium       Plasma 0.078 ng/mL LC/MS/MS Validated
A Valsartan        Plasma 0.020 µg/mL LC/MS/MS Validated
A Valsartan and
Hydrochlorothiazide
Plasma 0.050
2.000
µg/mL
ng/mL
LC/MS/MS Validated
A Vilazodone Plasma 0.506 ng/mL LC/MS/MS Validated
A Warfarin         Plasma 5.145 ng/mL LC/MS/MS Validated
A Zolpidem        Plasma 1.300 ng/mL LC/MS/MS Validated
A Zolmitriptan
N-Desmethyl Zolmitriptan
Plasma 0.300 ng/mL LC/MS/MS Validated
A 6-Acetylmorphine Plasma 25.00 ng/mL LC/MS/MS Developed
A Alprazolam Plasma 0.10 ng/mL LC/MS/MS Developed
A Amlodipine
Hydrochlorothiazide
Valsartan
Plasma 0.15
2.00
40.0
ng/mL
ng/mL ng/mL
LC/MS/MS Developed
A Atovaquone    Plasma 25.00 ng/mL LC/MS/MS Developed
A Cefuroxime     Plasma 25.00 ng/mL LC/MS/MS Developed
A Cetirizine        Plasma 0.50 ng/mL LC/MS/MS Developed
A Clonazepam Plasma 0.10 ng/mL LC/MS/MS Developed
A Diazepam Plasma 2.00 ng/mL LC/MS/MS Developed
A Doxazosin Plasma 0.10 ng/mL LC/MS/MS Developed
A Enalapril/
Enalaprilat
Plasma 0.50
0.50
ng/mL
ng/mL
LC/MS/MS Developed
A Esomeprazole Plasma 10.00 ng/mL LC/MS/MS Developed
A Felodipine Plasma 0.20 ng/mL LC/MS/MS Developed
A Flunitrazepam Plasma 0.50 ng/mL LC/MS/MS Developed
A Flurazepam Plasma 0.75 ng/mL LC/MS/MS Developed
A Losartan and Losartan caboxylic acid Plasma 5.00 ng/mL LC/MS/MS Developed
A Methadone Plasma 0.10 ng/mL LC/MS/MS Developed
A Misoprostolic acid Plasma 8.00 pg/mL LC/MS/MS Developed
A Norfentanyl Plasma 0.10 ng/mL LC/MS/MS Developed
A Oxymorphone Urine 25.00 ng/mL LC/MS/MS Developed
A Propranolol     Plasma 1.00 ng/mL LC/MS/MS Developed
A Amoxicillin
Clavulanic acid
Plasma 0.040
0.020
µg/mL LC/MS/MS Developed
A 7-Aminoflunitrazepam Plasma 12.00 ng/mL LC/MS/MS Development
A Alpha-hydroxyalprazolam Urine 12.00 ng/mL LC/MS/MS Development
A Amoxycillin Plasma 100.00 ng/mL LC/MS/MS Development
A Donepezil Plasma 1.00 ng/mL LC/MS/MS Development
A EDDP Urine 12.00 ng/mL LC/MS/MS Development
A Estron Sulfate
Equilin
Plasma 5.00
5.00
ng/mL LC/MS/MS Development
A Felbamate Plasma 0.25 µg/mL LC/MS/MS Development
A Linezolid Plasma 50.00 ng/mL LC/MS/MS Development
A Loratadine Plasma 40.00 pg/mL LC/MS/MS Development
A Meprobamate Urine 12.00 ng/mL LC/MS/MS Development
A Meperidine Urine 2.50 ng/mL LC/MS/MS Development
A Midazolam Plasma 0.10 ng/mL LC/MS/MS Development
A Nimodipine Plasma 0.10 ng/mL LC/MS/MS Development
A Nordiazepam Urine 12.00 ng/mL LC/MS/MS Development
A Normeperidine Urine 2.50 ng/mL LC/MS/MS Development
A Oxcarbazepine Plasma 50.00 ng/mL LC/MS/MS Development
A Perindopril
Perindoprilat
Plasma 0.50
0.25
ng/mL LC/MS/MS Development
A Repaglinide Plasma 0.30 ng/mL LC/MS/MS Development
A Telmisartan Plasma 4.00 ng/mL LC/MS/MS Development
A Tramterene
Hydrochlorothiazide
Plasma 0.10 ng/mL LC/MS/MS Development
A Triazolam Urine 12.00 ng/mL LC/MS/MS Development
A Venlafaxine Plasma 1.00 ng/mL LC/MS/MS Development
A Ziprasidone Plasma 0.40 ng/mL LC/MS/MS Development
A Aceclofenac Plasma 100.00 ng/mL LC/MS/MS Experience
D Amitriptyline Plasma 0.200 ng/mL LC/MS/MS Experience
D Atenolol Plasma 10.00 ng/mL LC/MS/MS Experience
D Citalopram Plasma 0.500 ng/mL LC/MS/MS Experience
D Clarithromycin Plasma 2.000 ng/mL LC/MS/MS Experience
D Clavulanic Acid Plasma 50.000 ng/mL LC/MS/MS Experience
D Desloratadine Plasma 0.100 ng/mL LC/MS/MS Experience
D Desmopressin Plasma 5.000 pg/mL LC/MS/MS Experience
D Duloxetine Plasma 0.200 ng/mL LC/MS/MS Experience
A Escitalopram Plasma 0.500 ng/mL LC/MS/MS Experience
D Galantamine Plasma 5.000 ng/mL LC/MS/MS Experience
A Glibenclamide Plasma 1.000 ng/mL LC/MS/MS Experience
D Gliclazide Plasma 3.000 ng/mL LC/MS/MS Experience
D Glimepiride Plasma 2.000 ng/mL LC/MS/MS Experience
D Indomethacin Plasma 20.000 ng/mL LC/MS/MS Experience
D Isosorbide Mononitrate Plasma TBD ng/mL LC/MS/MS Experience
D Ketoconazole Plasma 5.000 ng/mL LC/MS/MS Experience
D Lacidipine Plasma 0.050 ng/mL LC/MS/MS Experience
D Lamivudine Plasma 6.000 ng/mL LC/MS/MS Experience
D Lercanidipine Plasma TBD ng/mL LC/MS/MS Experience
D Levodopa Plasma 10.000 ng/mL LC/MS/MS Experience
D Meloxicam Plasma 10.000 ng/mL LC/MS/MS Experience
D Modafinil Plasma 20.000 ng/mL LC/MS/MS Experience
D Nisoldipine Plasma 0.20 ng/mL LC/MS/MS Experience
D Ondasetron Plasma 1.00 ng/mL LC/MS/MS Experience
D Oxybutynin Plasma 0.20 ng/mL LC/MS/MS Experience
D Pentazosin Plasma TBD ng/mL LC/MS/MS Experience
D Pravastatin Plasma 0.50 ng/mL LC/MS/MS Experience
D Ramipril
Ramiprilat
Plasma 0.10
0.10
ng/mL LC/MS/MS Experience
D Rhein Plasma 20.00 ng/mL LC/MS/MS Experience
D Risperidone Plasma 0.50 ng/mL LC/MS/MS Experience
D Ropinirole Plasma 20.00 pg/mL LC/MS/MS Experience
D Rosiglitazone Plasma 1.00 ng/mL LC/MS/MS Experience
D Sertraline Plasma 0.25 ng/mL LC/MS/MS Experience
D Stavudine Plasma 20.00 ng/mL LC/MS/MS Experience
D Sumatriptan Plasma 0.20 ng/mL LC/MS/MS Experience
D Tamsulosin Plasma 0.25 ng/mL LC/MS/MS Experience
D Terbinafine Plasma 10.00 ng/mL LC/MS/MS Experience
D Tolterodine
OH- Tolterodine
Plasma 0.05
0.05
ng/mL LC/MS/MS Experience
D Trandolapril
Trandolaprilat
Plasma 0.10
0.10
ng/mL LC/MS/MS Experience
D Ursodiol Plasma 100.00 ng/mL LC/MS/MS Experience
D Valacyclovir Plasma 50.00 ng/mL LC/MS/MS Experience
D Valaproic Acid Plasma 100.00 ng/mL LC/MS/MS Experience
D Verapamil Plasma 1.00 ng/mL LC/MS/MS Experience
D Zidovudine Plasma 6.00 ng/mL LC/MS/MS Experience